Overview of the clinical efficacy and safety of eldecalcitol for the treatment of osteoporosis

ConclusionsThis systematic review indicated that ELD was superior than alfacalcidol for improving vertebral fracture risk and BMD. Further large-scale trials should be conducted to verify the long-term effects and safety of ELD in osteoporosis.Prospero registration numberCRD42020147518.

http://rd.springer.com/10.1007/s11657-022-01071-3

Source: Archives of Orthopaedic and Trauma Surgery - May 5, 2022 Category: Orthopaedics Source Type: research